-
Mashup Score: 4TECLISTAMAB (TEC) STEP-UP DOSING (SUD) AND TREATMENT DOSE SCHEDULE... by Rahul Banerjee - 2 day(s) ago
EHA Library; Banerjee R. Jun 13 2024; 421056;
Source: library.ehaweb.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 23
EHA Library; Eyre T. Jun 13 2024; 420720;
Source: library.ehaweb.orgCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 0
EHA Library; Pollyea D. May 18 2017; 180699;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 17MINI-CONSOLIDATIONS VERSUS INTERMEDIATE-DOSE CYTARABINE (IDAC) FOR... by Christian Récher - 3 day(s) ago
EHA Library; Récher C. Jun 13 2024; 422253;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 11COMPLETED DOSE ESCALATION FROM THE FIRST-IN-HUMAN, PHASE 1/2 STUDY... by Sylvain Garciaz - 3 day(s) ago
EHA Library; Garciaz S. Jun 13 2024; 422250;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 50VENETOCLAX-HMA AS A BRIDGE TOWARDS HSCT OR DLI IN R/R AML: A... by Kathelijn Verdeyen - 3 day(s) ago
EHA Library; Verdeyen K. Jun 13 2024; 422241;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 7PHASE 1/2 STUDY OF ORAL DECITABINE/CEDAZURIDINE WITH VENETOCLAX AND... by Alex Bataller - 3 day(s) ago
EHA Library; Bataller A. Jun 13 2024; 422243;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 29
EHA Library; Ruhnke L. Jun 13 2024; 422239;
Source: library.ehaweb.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 37IDECABTAGENE VICLEUCEL (IDE-CEL) IN PATIENTS (PTS) WITH CLINICAL... by Dr. Xavier Leleu - 4 day(s) ago
EHA Library; Leleu X. Jun 13 2024; 422312;
Source: library.ehaweb.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 15
EHA Library; Dong S. Jun 13 2024; 420982;
Source: library.ehaweb.orgCategories: General Medicine News, Partners & KOLsTweet
3/ Relevantly just in time for #EHA2024: #MMsm teclistamab RWE: over a third of pts switched q1wk ➡️ q2wk before 6 mo (data cutoff 11/2023, so before FDA/EC label change). ⬇️ time tox, and (as others have shown), ⬇️ infections & comparable efficacy! https://t.co/LxFT49xC6A https://t.co/E72Gc4ubRi